Skip to main content

Table 4 The genotypes of MUC5B promoter polymorphism as regards the smoking status among the 3 studied groups

From: A preliminary study: MUC5B promoter polymorphism and its association with IPF

Genotype Smokers Non smokers P value
IPF patients (group I)    
GT and TT 13 (50%) 13 (50%) 0.014
GG 2 (12.5%) 14 (87.5)  
Other ILD patients (group II)    
GT and TT 2 (11.8%) 15 (88.2%) 0.850
GG 3 (10%) 27 (90%)  
Control subjects (group III)    
GT and TT 2 (25%) 6 (75%) 0.650
GG 6 (18.8%) 26 (81.3%)